CCR2 and neoplasm: Therefore, we concluded that SBRT followed by αPD-1 treatment and a prolonged treatment course of CCR2/5i was the best treatment strategy among all therapies that had been tested thus far for this mouse model of orthotopically implanted KPC tumor.